DOMINEE EHRHARDT: Open Payments
NPI 1083020788 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 40 payments from 14 companies in 2025. Trend: 2023 $632 · 2024 $633 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $192 |
| Novo Nordisk Inc | 6 | $119 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| PFIZER INC. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Viatris Specialty LLC | 2 | $42 |
| Exact Sciences Corporation | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: VRAYLAR, REXULTI, CAPLYTA, JARDIANCE, QULIPTA, Wegovy, YUPELRI, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
